Comparative efficacy of a DA2/alpha2 agonist and a beta-blocker in reducing adrenergic drive and cardiac fibrosis in an experimental model of left ventricular dysfunction after coronary artery occlusion

Journal of Cardiovascular Pharmacology
Roberto LatiniS Bongrani

Abstract

Attenuation of neuroendocrine activation may be beneficial in congestive heart failure. Sympathetic nervous system overactivity can be reduced by receptors blockade or by reducing norepinephrine (NE) spillover. This study evaluated and compared the effects of a DA2-dopaminergic receptor/alpha2-adrenoceptor agonist (CHF-1024) and a beta1-adrenoreceptor antagonist in terms of hemodynamics, ventricular remodeling, beta-adrenergic drive, and cardiac fibrosis after myocardial infarction (MI) in rats. MI was induced by left coronary artery ligation in 213 rats, whereas 12 were left unoperated on. After 2 months, the operated-on animals were treated for 1 more month with CHF-1024 at either 0.33 mg/kg/day (low dose) or 1 mg/kg/day (high dose) or with metoprolol (10 mg/kg/day), delivered through implanted osmotic minipumps. Plasma concentration and urinary excretion of NE were measured before the rats were killed. Hemodynamic variables were measured and morphometric analysis was done on the diastole-arrested hearts to quantify left ventricular remodeling and interstitial collagen density. Metoprolol treatment tended to normalize LV end-diastolic pressure (LVEDP). CHF-1024 at either dose, and metoprolol, significantly reduced collagen de...Continue Reading

References

Dec 1, 1977·The Journal of Clinical Endocrinology and Metabolism·G NorbiatoC Moroni
Jan 1, 1990·The Biochemical Journal·S TakahashiS M Factor
Jul 1, 1985·Circulation Research·J M PfefferE Braunwald
Sep 27, 1984·The New England Journal of Medicine·J N CohnT Rector
Aug 1, 1995·Journal of Pharmacological and Toxicological Methods·S PorzioR Latini
Jun 1, 1995·Journal of Molecular and Cellular Cardiology·J P CleutjensK T Weber
Oct 1, 1995·Journal of Cardiovascular Pharmacology·S K LaycockJ R Parratt
Dec 1, 1995·European Heart Journal·F Zannad

❮ Previous
Next ❯

Citations

Sep 5, 2001·International Journal of Cardiology·D J van Veldhuisen, P A Poole-Wilson
Jul 18, 2000·Journal of the American College of Cardiology·S WeiJ E Sanderson
Nov 5, 2003·Pharmacological Research : the Official Journal of the Italian Pharmacological Society·Evasio PasiniRoberto Ferrari

❮ Previous
Next ❯

Related Concepts

Related Feeds

Adrenergic Receptors: Trafficking

Adrenergic receptor trafficking is an active physiological process where adrenergic receptors are relocated from one region of the cell to another or from one type of cell to another. Discover the latest research on adrenergic receptor trafficking here.

Cardiac Remodeling

Cardiac remodeling in response to a myocardial infarction is characterized by progressive ventricular dilatation, cardiac hypertrophy, fibrosis, and deterioration of cardiac performance. Discover the latest research on Cardiac Remodeling here.